Additional Inventions definition

Additional Inventions means discoveries and inventions that (i) are necessary or useful for the development, manufacture or commercialization of Licensed Products within the Field, and (ii) are developed in the laboratories of Drs. Jan Van Deursen, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ and/or ▇▇▇▇▇▇ ▇▇▇▇▇ at Mayo during the IP Capture Period, excluding inventions generated pursuant to the Research Agreement and subject to the terms thereof.
Additional Inventions means domestic and foreign patent applications and patents (including, without limitation, reissues or temporal extensions of same) on inventions conceived and discoveries made: (a) which are assigned by UVA to Foundation; (b) which are invented or discovered by ▇▇. ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and/or ▇▇. ▇▇▇▇ ▇▇; (c) which are relevant to the Field; (d) for which Adial has timely exercised its option to include such patent applications and patents hereunder, which option is provided for in Section 2.2; and (e) which are invented within three (3) years after the Effective Date.
Additional Inventions means, any and all Know-How proprietary to LR and/or any of its Affiliates, which is required and necessary and/or beneficial in the exploitation of the License and that are not included in the Licensed Information (as such term is defined below), which shall be provided to MediWound for no further consideration;

Examples of Additional Inventions in a sentence

  • Under the terms of the License Agreement, Graphite is obtaining this exclusive option to license the Additional Inventions and upon exercise of this option, the Additional Inventions would be included in the Licensed Patents (as defined below) and Technology (as defined below) licensed to Graphite under the License Agreement in each case via an amendment to the License Agreement.

  • Stanford wants to have the Additional Inventions perfected and marketed as soon as possible so that resulting products may be available for public use and benefit.

  • However, UMMS makes no representation or warranty that the company does not dispute that nor that it will not institute legal action to make claims to the Additional Inventions nor that such legal action will not have any adverse effect on CytRx’s rights to practice the Patent Rights (as defined in the Amended License Agreement).

  • UMMS will exercise its best efforts to clarify that the sponsored research agreement with the prior company has been effectively terminated and that such prior company has no license to or other interest in the Additional Inventions or other further rights or options under that sponsored research agreement.

  • CytRx acknowledges that the Additional Inventions are the subject of a sponsored research agreement with another company that UMMS has terminated.

  • In consideration for the forgoing assignment of the Additional Inventions, and subject to the terms of this Agreement, SDP hereby grants to LPI the worldwide, exclusive, royalty-free, paid-up, and irrevocable license right to use the Subject Patent Rights for LPI to use to develop, make, have made, use, sell and import products and to practice methods and processes, only within the Permitted Fields (as defined below).

  • BURF shall take reasonable actions to assure that those researchers exercising the Retained Rights promptly make invention disclosures to BURF regarding any Additional Inventions and delay publication of information regarding such Additional Inventions to the extent necessary to allow time for the preparation and filing of patent applications.

  • Attached hereto as Exhibit A is a combined listing of the Additional Inventions and the previously assigned inventions and related patent rights (collectively called the ‘Subject Patent Rights”).

  • In such event, the Parties shall sign an amended Exhibit A-1 to add the Additional Inventions and Patents thereto and in the event that Purchaser’s notification to Seller is subsequent to the Closing, then the Parties shall conduct a subsequent closing and the provisions of Section 7.1 shall apply to the sale, assignment transfer and setting over to Purchaser of the Additional Inventions and Patents, mutatis mutandis.

  • The Option shall apply to all Additional Inventions made during the term of this Agreement, and Licensee's exercise or failure to exercise the Option with *** Information redacted pursuant to a confidential treatment request.

Related to Additional Inventions

  • Company Inventions means any and all Inventions (and all Intellectual Property Rights related to Inventions) that are made, conceived, developed, prepared, produced, authored, edited, amended, reduced to practice, or learned or set out in any tangible medium of expression or otherwise created, in whole or in part, by me, either alone or with others, during my employment by Company, and all printed, physical, and electronic copies, and other tangible embodiments of Inventions.

  • Joint Inventions has the meaning set forth in Section 9.1.

  • Inventions means all discoveries, concepts and ideas, whether patentable or not, including but not limited to, processes, methods, formulas, compositions, techniques, articles and machines, as well as improvements thereof or “know-how” related thereto, relating at the time of conception or reduction to practice to the business engaged in by the Company, or any actual or anticipated research or development by the Company.

  • Background Invention means an Invention conceived and first actually reduced to practice before the Effective Date.

  • Prior Inventions means all inventions, original works of authorship, developments, concepts, sales methods, improvements, trade secrets or similar intellectual property, whether or not patentable or registrable under copyright or similar laws, that relate to any Cigna company’s current or proposed business, work products or research and development which you conceived, developed, reduced to practice or fixed before your Cigna company employment and which belong to you.